| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | SMARCA5 TOX ATRX FOSL2 GATA4 APBB1 MORC2 KLF4 CLOCK HDAC7 MEF2A BAHD1 PHF1 KDM4D NFATC1 SCMH1 CHD5 SMARCA1 TAF1 | 3.23e-05 | 739 | 177 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.15e-04 | 54 | 177 | 5 | GO:0001223 | |
| GeneOntologyMolecularFunction | histone binding | 1.32e-04 | 265 | 177 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.32e-04 | 88 | 177 | 6 | GO:0140034 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.12e-04 | 229 | 177 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | linear polyubiquitin binding | 2.33e-04 | 3 | 177 | 2 | GO:1990450 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.55e-04 | 140 | 177 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.14e-04 | 37 | 177 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | phosphorylase kinase activity | 4.63e-04 | 4 | 177 | 2 | GO:0004689 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 5.15e-04 | 206 | 177 | 8 | GO:0140030 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 7.68e-04 | 5 | 177 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.01e-03 | 86 | 177 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.01e-03 | 86 | 177 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.08e-03 | 51 | 177 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription factor binding | ATF7 TBX3 CAND2 MED16 GATA4 APBB1 KLF4 CLOCK HDAC7 MEF2A PHF1 NFATC1 SMARCA1 AHR TAF1 MAP3K7 | 1.12e-03 | 753 | 177 | 16 | GO:0008134 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TET2 BRPF3 SMARCA5 TOX ATRX MED16 APBB1 MORC2 ZZEF1 CLOCK HDAC7 BAHD1 TASOR2 HMG20B PHF1 KDM4D KANSL1 SCMH1 CHD5 MDC1 SMARCA1 AHR KDM2A TAF1 BRD1 MAP3K7 METTL22 | 8.29e-08 | 999 | 174 | 27 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 BRPF3 SMARCA5 TOX ATRX APBB1 MORC2 ZZEF1 CLOCK HDAC7 BAHD1 TASOR2 HMG20B PHF1 KDM4D KANSL1 SCMH1 CHD5 MDC1 SMARCA1 KDM2A TAF1 BRD1 MAP3K7 METTL22 | 1.46e-07 | 896 | 174 | 25 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 BRPF3 SMARCA5 ATRX APBB1 MORC2 CLOCK HDAC7 BAHD1 TASOR2 HMG20B PHF1 KDM4D SCMH1 CHD5 SMARCA1 KDM2A TAF1 BRD1 MAP3K7 METTL22 | 1.24e-06 | 741 | 174 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | neuron development | SLC25A46 MYT1L TNIK TOX MAP6 WEE1 TRPC5 SHC1 APBB1 DNM1L FRYL PLXND1 ZMIZ1 KLF4 MEF2A B4GALT5 CASK MAGI2 GDPD5 FRY KHDC3L DOCK7 KCNMA1 NUMB SEMA6A MAP3K13 MAPK6 STK24 ALK MOV10 | 5.02e-06 | 1463 | 174 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | SLC25A46 TNIK TOX MAP6 WEE1 TRPC5 SHC1 APBB1 DNM1L FRYL PLXND1 KLF4 MEF2A B4GALT5 CASK MAGI2 GDPD5 FRY KHDC3L DOCK7 NUMB SEMA6A MAP3K13 MAPK6 STK24 ALK MOV10 | 1.03e-05 | 1285 | 174 | 27 | GO:0031175 |
| GeneOntologyBiologicalProcess | mitochondrial membrane fission | 7.08e-05 | 2 | 174 | 2 | GO:0090149 | |
| GeneOntologyBiologicalProcess | lung connective tissue development | 7.08e-05 | 2 | 174 | 2 | GO:0060427 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | TNIK TOX MAP6 TRPC5 APBB1 DNM1L PLXND1 CASK MAGI2 KHDC3L NUMB MAP3K13 STK24 ALK | 8.08e-05 | 494 | 174 | 14 | GO:0031346 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MYT1L FOXM1 TET2 ATF7 TBX3 SMARCA5 TOX ATRX MED16 FOSL2 GATA4 APBB1 IKBKG ZMIZ1 KLF4 CLOCK MEF2A CASK NFATC1 EGR3 MDC1 SMARCA1 AHR ELK3 TAF1 MAML2 | 1.08e-04 | 1390 | 174 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | dendrite development | SLC25A46 TNIK MAP6 TRPC5 DNM1L MEF2A CASK KHDC3L NUMB MAPK6 ALK | 1.35e-04 | 335 | 174 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MYT1L FOXM1 SOX5 ATF7 TBX3 SMARCA5 SHC1 GATA4 APBB1 ZNF205 BRMS1L MORC2 KLF4 CLOCK HDAC7 MEF2A BAHD1 ZBTB32 NFATC1 NACC2 SCMH1 CHD5 AHR KDM2A ELK3 TAF1 | 1.40e-04 | 1413 | 174 | 26 | GO:1902679 |
| GeneOntologyCellularComponent | chromatin | MYT1L FOXM1 SOX5 ATF7 TBX3 BRPF3 SMARCA5 ATRX FOSL2 GATA4 BRMS1L ZMIZ1 MORC2 KLF4 CLOCK MEF2A KDM4D ZBTB32 KANSL1 PHF20L1 NFATC1 NACC2 EGR3 CHD5 SMARCA1 AHR NFXL1 KDM2A ELK3 TAF1 BRD1 MAP3K7 | 9.24e-07 | 1480 | 178 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.19e-05 | 6 | 178 | 3 | GO:0097728 | |
| Domain | Zinc_finger_PHD-type_CS | 2.77e-06 | 65 | 178 | 7 | IPR019786 | |
| Domain | GOLGA6L | 1.67e-05 | 6 | 178 | 3 | IPR026737 | |
| Domain | ZF_PHD_1 | 3.71e-05 | 96 | 178 | 7 | PS01359 | |
| Domain | Cell_morpho_N | 9.03e-05 | 2 | 178 | 2 | IPR025614 | |
| Domain | SLIDE | 9.03e-05 | 2 | 178 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 9.03e-05 | 2 | 178 | 2 | IPR015194 | |
| Domain | Cell_Morphogen_C | 9.03e-05 | 2 | 178 | 2 | IPR025481 | |
| Domain | MOR2-PAG1_mid | 9.03e-05 | 2 | 178 | 2 | IPR029473 | |
| Domain | SLIDE | 9.03e-05 | 2 | 178 | 2 | PF09111 | |
| Domain | HAND | 9.03e-05 | 2 | 178 | 2 | PF09110 | |
| Domain | MOR2-PAG1_mid | 9.03e-05 | 2 | 178 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 9.03e-05 | 2 | 178 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 9.03e-05 | 2 | 178 | 2 | PF14222 | |
| Domain | DENND6 | 9.03e-05 | 2 | 178 | 2 | IPR024224 | |
| Domain | ISWI | 9.03e-05 | 2 | 178 | 2 | IPR029915 | |
| Domain | Laminin_G | 2.26e-04 | 58 | 178 | 5 | IPR001791 | |
| Domain | SNF2_N | 2.33e-04 | 32 | 178 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.33e-04 | 32 | 178 | 4 | PF00176 | |
| Domain | Glyco_hydro_15/PHK | 2.69e-04 | 3 | 178 | 2 | IPR011613 | |
| Domain | PHK_A/B_su | 2.69e-04 | 3 | 178 | 2 | IPR008734 | |
| Domain | DBINO | 2.69e-04 | 3 | 178 | 2 | IPR020838 | |
| Domain | Glyco_hydro_15 | 2.69e-04 | 3 | 178 | 2 | PF00723 | |
| Domain | DBINO | 2.69e-04 | 3 | 178 | 2 | PF13892 | |
| Domain | ZF_PHD_2 | 2.97e-04 | 95 | 178 | 6 | PS50016 | |
| Domain | DEAH_ATP_HELICASE | 4.57e-04 | 38 | 178 | 4 | PS00690 | |
| Domain | Znf_FYVE_PHD | 5.27e-04 | 147 | 178 | 7 | IPR011011 | |
| Domain | ABL9/DENND6_dom | 5.35e-04 | 4 | 178 | 2 | IPR018307 | |
| Domain | Avl9 | 5.35e-04 | 4 | 178 | 2 | PF09794 | |
| Domain | GOLGA2L5 | 6.25e-04 | 18 | 178 | 3 | PF15070 | |
| Domain | ATP_grasp_subdomain_1 | 6.25e-04 | 18 | 178 | 3 | IPR013815 | |
| Domain | Golgin_A | 6.25e-04 | 18 | 178 | 3 | IPR024858 | |
| Domain | LamG | 8.04e-04 | 44 | 178 | 4 | SM00282 | |
| Domain | Znf_PHD-finger | 9.48e-04 | 79 | 178 | 5 | IPR019787 | |
| Pubmed | MYT1L FOXM1 SOX5 ATF7 TBX3 SMARCA5 TOX FOSL2 RHOBTB3 GATA4 IKBKG ZNF205 KLF4 CLOCK MEF2A HMG20B PHF1 HIVEP3 PHF20L1 NFATC1 LPP AHR | 3.24e-10 | 808 | 182 | 22 | 20412781 | |
| Pubmed | CEP104 TET2 BRPF3 TBRG4 CAND2 MLEC RHOBTB3 PLXND1 ZZEF1 CLOCK BAHD1 NRXN2 CHD5 MDC1 MAML2 CPSF2 | 2.27e-08 | 529 | 182 | 16 | 14621295 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXM1 ATF7 SMARCA5 FOSL2 GATA4 BRMS1L MORC2 MEF2A HMG20B PHKA2 KANSL1 PHF20L1 NFATC1 NACC2 SMARCA1 NFXL1 KDM2A CPSF2 MOV10 | 1.43e-07 | 857 | 182 | 19 | 25609649 |
| Pubmed | 3.41e-07 | 225 | 182 | 10 | 12168954 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATF7 DNAJC13 TTLL3 ATRX FOSL2 WASF3 TNRC6B FRYL ZMIZ1 MEF2A TASOR2 CASK HIVEP3 SNX30 NFATC1 NACC2 LPP KCNMA1 NUMB KDM2A SEMA6A ELK3 IGSF9B MAPK6 | 1.04e-06 | 1489 | 182 | 24 | 28611215 |
| Pubmed | SOX5 TET2 SMARCA5 ATRX MRPS12 RBM33 GATA4 IKBKG TNRC6B BRMS1L ZMIZ1 MORC2 KLF4 MEF2A HMG20B KANSL1 CHD5 MDC1 SMARCA1 ELK3 TAF1 CPSF2 MOV10 | 1.83e-06 | 1429 | 182 | 23 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 TET2 TBX3 SMARCA5 GATA4 BRMS1L ZMIZ1 HMG20B MDC1 SMARCA1 TAF1 | 2.72e-06 | 351 | 182 | 11 | 38297188 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | TBX3 SMARCA5 ATRX GART CASK MAGI2 MDC1 NUMB SEMA6A TAF1 MOV10 | 3.29e-06 | 358 | 182 | 11 | 32460013 |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 28974699 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | PRPSAP1 TET2 DNAJC13 TNRC6B ZNF205 FRYL B4GALT5 KANSL1 LPP ELK3 BRD1 STK24 ADIPOR2 | 5.59e-06 | 536 | 182 | 13 | 15840001 |
| Pubmed | PRPSAP1 TET2 DNAJC13 TNRC6B ZNF205 FRYL B4GALT5 KANSL1 LPP ELK3 BRD1 STK24 ADIPOR2 | 5.82e-06 | 538 | 182 | 13 | 10512203 | |
| Pubmed | 5.88e-06 | 130 | 182 | 7 | 12421765 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MRPS12 FOSL2 SHC1 SLCO4A1 FRYL PLXND1 KLF4 ZZEF1 HDAC7 BAHD1 HIVEP3 GDPD5 SNX30 AATK KANSL1 NFATC1 CHD5 SUMF1 AHNAK2 | 6.10e-06 | 1105 | 182 | 19 | 35748872 |
| Pubmed | WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. | 7.74e-06 | 8 | 182 | 3 | 32518374 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ISYNA1 ATRX TNRC6B YTHDC2 MORC2 CASK PHKA1 FRY KANSL1 KCNMA1 IGSF9B STK24 | 8.61e-06 | 475 | 182 | 12 | 31040226 |
| Pubmed | 1.12e-05 | 263 | 182 | 9 | 34702444 | ||
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 1.16e-05 | 9 | 182 | 3 | 7874112 | |
| Pubmed | 1.30e-05 | 268 | 182 | 9 | 33640491 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 STIM2 WEE1 APBB1 USP43 DNM1L FRYL DNAH7 HDAC7 ARHGEF10 LPP DOCK7 NUMB NHS BRD1 AHNAK2 | 1.34e-05 | 861 | 182 | 16 | 36931259 |
| Pubmed | 1.42e-05 | 99 | 182 | 6 | 34161765 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 SMARCA5 DNAJC13 ATRX WEE1 FOSL2 SLCO4A1 YTHDC2 MORC2 HDAC7 KANSL1 MDC1 TRAPPC10 ELK3 CPSF2 | 1.55e-05 | 774 | 182 | 15 | 15302935 |
| Pubmed | SLC25A46 TNIK DNM1L ELFN2 CASK MAGI2 TRAPPC10 NUMB MAP3K13 CPSF2 TUBAL3 | 1.83e-05 | 430 | 182 | 11 | 32581705 | |
| Pubmed | TBX3 BRPF3 SMARCA5 DCDC1 WEE1 RHOBTB3 GATA4 TNRC6B YTHDC2 BRMS1L ZZEF1 HMG20B EML5 CHD5 SMARCA1 AHR TAF1 BRD1 | 2.53e-05 | 1116 | 182 | 18 | 31753913 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYT1L FOXM1 SOX5 ATF7 TBX3 FOSL2 GATA4 ZNF205 KLF4 CLOCK MEF2A HIVEP3 NFATC1 EGR3 NFXL1 ELK3 | 2.55e-05 | 908 | 182 | 16 | 19274049 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | STIM2 ATRX MED16 WEE1 SHC1 IKBKG PHKA1 PHKA2 GTF2H4 NUMB IGSF9B MAP3K13 MAPK6 MAP3K7 STK24 TUBAL3 | 2.62e-05 | 910 | 182 | 16 | 36736316 |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8226841 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 16360132 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 22573816 | ||
| Pubmed | ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. | 2.72e-05 | 2 | 182 | 2 | 15226403 | |
| Pubmed | Elk-3 is a KLF4-regulated gene that modulates the phagocytosis of bacteria by macrophages. | 2.72e-05 | 2 | 182 | 2 | 25351511 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 26807827 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 39062631 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 32299913 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 21828262 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8733133 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 31150793 | ||
| Pubmed | TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. | 2.72e-05 | 2 | 182 | 2 | 31207603 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 27353300 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 31461795 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 1372435 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 17217053 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 29890853 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 29890823 | ||
| Pubmed | Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction. | 2.72e-05 | 2 | 182 | 2 | 23140583 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 31253396 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 3.00e-05 | 12 | 182 | 3 | 27824329 | |
| Pubmed | 4.77e-05 | 75 | 182 | 5 | 25593309 | ||
| Pubmed | Large-scale genotyping identifies 41 new loci associated with breast cancer risk. | 5.08e-05 | 76 | 182 | 5 | 23535729 | |
| Pubmed | Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. | 6.12e-05 | 15 | 182 | 3 | 23986494 | |
| Pubmed | STIM2 DNAJC13 CCDC146 APBB1 TNRC6B DNM1L SLC6A15 PLXND1 DNAH7 TASOR2 CASK DENND6A DOCK7 MAP3K7 | 6.54e-05 | 777 | 182 | 14 | 35844135 | |
| Pubmed | KPNA4 FOXM1 BRPF3 ATRX MRPS12 WEE1 SLCO4A1 KERA DNM1L C10orf90 MORC2 BAHD1 RTKN2 AHR NHS KDM2A MAML2 MAPK6 BRD1 | 7.42e-05 | 1327 | 182 | 19 | 32694731 | |
| Pubmed | TBRG4 COL12A1 CHST14 SHC1 GATA4 DNM1L KLF4 PHF1 NFATC1 LPP B9D1 MAML2 PLEKHH2 | 7.57e-05 | 689 | 182 | 13 | 36543142 | |
| Pubmed | Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity. | 8.14e-05 | 3 | 182 | 2 | 17827213 | |
| Pubmed | Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation. | 8.14e-05 | 3 | 182 | 2 | 32269263 | |
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 20214815 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 15647288 | ||
| Pubmed | TRIM14 promotes endothelial activation via activating NF-κB signaling pathway. | 8.14e-05 | 3 | 182 | 2 | 31070748 | |
| Pubmed | TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. | 8.14e-05 | 3 | 182 | 2 | 20478530 | |
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 36314527 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 23751499 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 35313071 | ||
| Pubmed | Genetic dissection of susceptibility to audiogenic seizures in inbred mice. | 8.14e-05 | 3 | 182 | 2 | 2052619 | |
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 12163407 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 23768840 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 21738833 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 11359880 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 9045663 | ||
| Pubmed | Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension. | 8.14e-05 | 3 | 182 | 2 | 37356737 | |
| Pubmed | USP15 regulates p66Shc stability associated with Drp1 activation in liver ischemia/reperfusion. | 8.14e-05 | 3 | 182 | 2 | 36163170 | |
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 21566132 | ||
| Pubmed | Glucoamylase-like domains in the alpha- and beta-subunits of phosphorylase kinase. | 8.14e-05 | 3 | 182 | 2 | 12876330 | |
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 36137995 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 32409930 | ||
| Pubmed | 8.14e-05 | 3 | 182 | 2 | 20837706 | ||
| Pubmed | Identification of APBB1 as a substrate for anaplastic lymphoma kinase. | 8.36e-05 | 44 | 182 | 4 | 39115278 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SMARCA5 ATRX GATA4 MORC2 PHF20L1 SCMH1 CHD5 MDC1 SMARCA1 KDM2A TAF1 BRD1 | 9.43e-05 | 608 | 182 | 12 | 36089195 |
| Pubmed | MYT1L FOXM1 SOX5 TBX3 TOX FOSL2 KLF4 MEF2A HMG20B PHF1 GTF2H4 AHR ELK3 | 1.01e-04 | 709 | 182 | 13 | 22988430 | |
| Pubmed | Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. | 1.09e-04 | 18 | 182 | 3 | 27695001 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.45e-04 | 150 | 182 | 6 | 28242625 | |
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 20106950 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 28607106 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 22595670 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 16289642 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 3472241 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 33139544 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 8786425 | ||
| Pubmed | Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. | 1.62e-04 | 4 | 182 | 2 | 11585834 | |
| Pubmed | TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. | 1.62e-04 | 4 | 182 | 2 | 17673906 | |
| Pubmed | Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. | 1.62e-04 | 4 | 182 | 2 | 18480379 | |
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 27854074 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 26677226 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 21634085 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 16980305 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 27048361 | ||
| Pubmed | Tmem178 acts in a novel negative feedback loop targeting NFATc1 to regulate bone mass. | 1.62e-04 | 4 | 182 | 2 | 26644563 | |
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 32915464 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 21709223 | ||
| Pubmed | 1.62e-04 | 4 | 182 | 2 | 21330364 | ||
| Pubmed | Genetic components of the circadian clock regulate thrombogenesis in vivo. | 1.62e-04 | 4 | 182 | 2 | 18413500 | |
| Pubmed | Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation. | 1.62e-04 | 4 | 182 | 2 | 35856559 | |
| Interaction | MBD3 interactions | KPNA4 TET2 ATF7 SMARCA5 ATRX GATA4 USP43 BRMS1L PHF1 PHF20L1 CHD5 SMARCA1 CPSF2 GOLGA6L9 | 4.44e-07 | 295 | 180 | 14 | int:MBD3 |
| Interaction | MTA3 interactions | SOX5 SMARCA5 GATA4 USP43 BRMS1L HMG20B PHF1 PHF20L1 NACC2 CHD5 SMARCA1 | 4.57e-07 | 173 | 180 | 11 | int:MTA3 |
| Interaction | LIN9 interactions | 6.84e-07 | 111 | 180 | 9 | int:LIN9 | |
| Interaction | HDAC1 interactions | KPNA4 TET2 TBX3 SMARCA5 DNAJC13 ATRX GATA4 APBB1 USP43 IKBKG TNRC6B BRMS1L ZMIZ1 KLF4 HDAC7 MEF2A BAHD1 HMG20B PHF1 PHF20L1 NFATC1 NACC2 CHD5 DOCK7 TAF1 CPSF2 STK24 | 1.97e-06 | 1108 | 180 | 27 | int:HDAC1 |
| Interaction | HDAC2 interactions | KPNA4 TNIK TET2 TBX3 SMARCA5 DNAJC13 GATA4 USP43 BRMS1L KLF4 HDAC7 BAHD1 HMG20B PHF1 PHF20L1 NFATC1 NACC2 CHD5 LPP NUMB CPSF2 MOV10 AHNAK2 | 2.95e-06 | 865 | 180 | 23 | int:HDAC2 |
| Interaction | CALCOCO2 interactions | KPNA4 TNIK TBRG4 GART SHC1 IKBKG ZNF205 DNM1L HDAC7 BAHD1 PHF1 KANSL1 TM9SF2 ARHGEF39 SHARPIN KDM2A | 7.94e-06 | 486 | 180 | 16 | int:CALCOCO2 |
| Interaction | BRMS1L interactions | 1.68e-05 | 125 | 180 | 8 | int:BRMS1L | |
| Interaction | HDAC4 interactions | TBX3 ISYNA1 ATRX GART SHC1 TNRC6B YTHDC2 MORC2 HDAC7 MEF2A CASK PHKA1 FRY KANSL1 NFATC1 KCNMA1 IGSF9B GOLGA6L9 STK24 | 3.95e-05 | 744 | 180 | 19 | int:HDAC4 |
| Interaction | SUDS3 interactions | 4.00e-05 | 141 | 180 | 8 | int:SUDS3 | |
| Interaction | MTA1 interactions | KPNA4 SMARCA5 ATRX GATA4 BRMS1L HMG20B PHF1 PHF20L1 NACC2 CHD5 SMARCA1 | 5.00e-05 | 283 | 180 | 11 | int:MTA1 |
| Interaction | KDR interactions | 6.20e-05 | 150 | 180 | 8 | int:KDR | |
| Interaction | GATAD2B interactions | KPNA4 TNIK SMARCA5 ATRX BRMS1L PHF1 PHF20L1 NFATC1 CHD5 SMARCA1 | 7.36e-05 | 245 | 180 | 10 | int:GATAD2B |
| GeneFamily | PHD finger proteins | 2.34e-05 | 90 | 115 | 6 | 88 | |
| GeneFamily | Collagens|Collagen proteoglycans | 3.96e-04 | 5 | 115 | 2 | 575 | |
| Coexpression | GSE45365_BCELL_VS_CD8_TCELL_UP | 6.72e-06 | 190 | 179 | 9 | M9991 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYT1L CELF5 STIM2 SYN3 ATRX MAP6 RBM33 SLC6A15 ZMIZ1 VWCE CASK HIVEP3 MAGI2 FRY AATK NRXN2 CHD5 KCNMA1 IGSF9B BRD1 AHNAK2 PDZRN4 | 7.15e-06 | 1106 | 179 | 22 | M39071 |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_UP | 7.63e-06 | 193 | 179 | 9 | M6735 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SLC25A46 FOXM1 TBX3 SMARCA5 TBRG4 ATRX MED16 SHC1 GATA4 MEF2A HMG20B PHF20L1 LPP CA7 | 1.43e-05 | 519 | 179 | 14 | M3395 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SLC25A46 FOXM1 TBX3 SMARCA5 TBRG4 ATRX MED16 SHC1 GATA4 MEF2A HMG20B PHF20L1 LPP CA7 | 2.36e-05 | 543 | 179 | 14 | MM997 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 2.97e-05 | 176 | 179 | 8 | M39223 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ATRX RHOBTB3 TNRC6B YTHDC2 BRMS1L CLOCK TGFBR2 SNX30 PHF20L1 TAF1 | 3.19e-05 | 289 | 179 | 10 | M2196 |
| Coexpression | SENESE_HDAC3_TARGETS_UP | TNIK DNAJC13 WEE1 CNTNAP3 SLC6A15 TASOR2 CASK TGFBR2 KCNMA1 AKR1C3 TRAPPC10 ELK3 PLEKHH2 | 3.85e-05 | 495 | 179 | 13 | M8451 |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 6.73e-05 | 146 | 179 | 7 | M41190 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 7.07e-05 | 199 | 179 | 8 | M6646 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 7.07e-05 | 199 | 179 | 8 | M5254 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS | 7.30e-05 | 102 | 179 | 6 | M43620 | |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 7.32e-05 | 200 | 179 | 8 | M3390 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 7.32e-05 | 200 | 179 | 8 | M3608 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 7.32e-05 | 200 | 179 | 8 | M9203 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SMARCA5 DNAJC13 ATRX RHOBTB3 WASF3 FRYL ZMIZ1 ZZEF1 CLOCK MEF2A CASK TGFBR2 ARHGEF10 SMARCA1 NUMB MAPK6 STK24 | 8.52e-05 | 856 | 179 | 17 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | CNTNAP3B FOSL2 GATA4 HDAC7 TGFBR2 FRY NACC2 TM7SF2 B9D1 ADAM33 SEMA6A STK24 MSLN AHNAK2 PDZRN4 | 1.05e-04 | 704 | 179 | 15 | M45672 |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 1.24e-04 | 161 | 179 | 7 | M40214 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TNIK CHST14 NEU3 ZNF205 PLXND1 HDAC7 NYNRIN SEMA6A ELK3 MAML2 | 4.07e-09 | 181 | 182 | 10 | fcc94f04dae98b817ec06b282d2e887804d37ae5 |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | CNTNAP3B RHOBTB3 CNTNAP3 MAGI2 PHKA1 GDPD5 NACC2 LPP NHS ALK | 1.06e-08 | 200 | 182 | 10 | 1276bfa911fddada4235e12e3081baa53164574b |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 3.07e-08 | 167 | 182 | 9 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-08 | 181 | 182 | 9 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-08 | 181 | 182 | 9 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-08 | 181 | 182 | 9 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.41e-08 | 185 | 182 | 9 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 193 | 182 | 9 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-07 | 196 | 182 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-07 | 200 | 182 | 9 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-07 | 200 | 182 | 9 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.44e-07 | 200 | 182 | 9 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.88e-07 | 173 | 182 | 8 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-07 | 175 | 182 | 8 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.61e-07 | 179 | 182 | 8 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.61e-07 | 179 | 182 | 8 | d24513a404c9b1d37dd47aa1cdb5713b64b88f89 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.61e-07 | 179 | 182 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.93e-07 | 180 | 182 | 8 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-07 | 181 | 182 | 8 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.99e-07 | 183 | 182 | 8 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.75e-07 | 185 | 182 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 187 | 182 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-06 | 187 | 182 | 8 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.06e-06 | 187 | 182 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 189 | 182 | 8 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.15e-06 | 189 | 182 | 8 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-06 | 190 | 182 | 8 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-06 | 190 | 182 | 8 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 190 | 182 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 190 | 182 | 8 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 190 | 182 | 8 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 190 | 182 | 8 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-06 | 190 | 182 | 8 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.29e-06 | 192 | 182 | 8 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-06 | 192 | 182 | 8 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 1.29e-06 | 192 | 182 | 8 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.34e-06 | 193 | 182 | 8 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.39e-06 | 194 | 182 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.39e-06 | 194 | 182 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 195 | 182 | 8 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-06 | 195 | 182 | 8 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 195 | 182 | 8 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 195 | 182 | 8 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.56e-06 | 197 | 182 | 8 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.56e-06 | 197 | 182 | 8 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-06 | 197 | 182 | 8 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 198 | 182 | 8 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 198 | 182 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 199 | 182 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 182 | 8 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.75e-06 | 200 | 182 | 8 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 182 | 8 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 200 | 182 | 8 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.75e-06 | 200 | 182 | 8 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 158 | 182 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 158 | 182 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.57e-06 | 166 | 182 | 7 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.57e-06 | 166 | 182 | 7 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-06 | 169 | 182 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.51e-06 | 170 | 182 | 7 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.51e-06 | 170 | 182 | 7 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.03e-06 | 172 | 182 | 7 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.30e-06 | 173 | 182 | 7 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 173 | 182 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 173 | 182 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 173 | 182 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.58e-06 | 174 | 182 | 7 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-06 | 174 | 182 | 7 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.17e-06 | 176 | 182 | 7 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.17e-06 | 176 | 182 | 7 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-06 | 176 | 182 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-06 | 177 | 182 | 7 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-06 | 177 | 182 | 7 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.80e-06 | 178 | 182 | 7 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 178 | 182 | 7 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.80e-06 | 178 | 182 | 7 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 179 | 182 | 7 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-06 | 180 | 182 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.46e-06 | 180 | 182 | 7 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.81e-06 | 181 | 182 | 7 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 183 | 182 | 7 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 183 | 182 | 7 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.05e-05 | 183 | 182 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 183 | 182 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 183 | 182 | 7 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 184 | 182 | 7 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-05 | 184 | 182 | 7 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-05 | 185 | 182 | 7 | c91e1081e630a61c18f6af6d198bfcf296746852 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 1.13e-05 | 185 | 182 | 7 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| Disease | creatinine measurement | SOX5 TET2 ATF7 DNAJC13 CAND2 DCDC1 TNRC6B SLC6A15 ETNPPL KLF4 FRY NRXN2 NFATC1 SCMH1 LPP DOCK7 KCNMA1 AHR NUMB PLEKHH2 | 2.27e-06 | 995 | 176 | 20 | EFO_0004518 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.86e-06 | 152 | 176 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.43e-05 | 131 | 176 | 7 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.43e-05 | 131 | 176 | 7 | C4552091 | |
| Disease | Juvenile arthritis | 1.43e-05 | 131 | 176 | 7 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.43e-05 | 131 | 176 | 7 | C3714758 | |
| Disease | severe acute respiratory syndrome, COVID-19 | SOX5 CCDC146 LGALS12 C10orf90 B4GALT5 CASK MAGI2 TGFBR2 GLDC KCNMA1 MAML2 CFAP53 | 1.69e-05 | 447 | 176 | 12 | EFO_0000694, MONDO_0100096 |
| Disease | Juvenile-Onset Still Disease | 1.74e-05 | 135 | 176 | 7 | C0087031 | |
| Disease | cortical surface area measurement | TNIK SOX5 TET2 CELF5 DCHS2 DNAJC13 DCDC1 TNRC6B SLC6A15 LGALS12 FRYL PLXND1 DNAH7 KANSL1 MDC1 SEMA6A ELK3 MAPK6 BRD1 MAP3K7 MOV10 PDZRN4 | 1.82e-05 | 1345 | 176 | 22 | EFO_0010736 |
| Disease | Schizophrenia | MYT1L TNIK SOX5 SYN3 MAP6 ETNPPL CLOCK MAGI2 RTKN2 EML5 NRXN2 EGR3 HTR3D BRD1 IL3RA ALK | 8.41e-05 | 883 | 176 | 16 | C0036341 |
| Disease | cortex volume change measurement | 9.00e-05 | 15 | 176 | 3 | EFO_0021500 | |
| Disease | Abnormality of the eye | 1.06e-04 | 3 | 176 | 2 | HP_0000478 | |
| Disease | cortical thickness | TNIK SOX5 CELF5 COL12A1 DCDC1 NUP210L TNRC6B SLC6A15 LGALS12 PLXND1 CLOCK ZBTB32 KANSL1 DOCK7 SHARPIN B9D1 MAP3K7 PDZRN4 | 1.27e-04 | 1113 | 176 | 18 | EFO_0004840 |
| Disease | Ischemic stroke | 1.52e-04 | 324 | 176 | 9 | HP_0002140 | |
| Disease | Glycogen phosphorylase kinase deficiency | 2.11e-04 | 4 | 176 | 2 | cv:C0268147 | |
| Disease | Sclerocystic Ovaries | 2.33e-04 | 144 | 176 | 6 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 2.33e-04 | 144 | 176 | 6 | C0032460 | |
| Disease | Adenoid Cystic Carcinoma | 3.40e-04 | 100 | 176 | 5 | C0010606 | |
| Disease | Cone-Rod Dystrophies | 3.50e-04 | 5 | 176 | 2 | C4085590 | |
| Disease | inflammatory bowel disease | 3.87e-04 | 449 | 176 | 10 | EFO_0003767 | |
| Disease | Flaccid Muscle Tone | 5.22e-04 | 6 | 176 | 2 | C0026825 | |
| Disease | Neonatal Hypotonia | 5.22e-04 | 6 | 176 | 2 | C2267233 | |
| Disease | Muscle Tone Atonic | 5.22e-04 | 6 | 176 | 2 | C0427202 | |
| Disease | Floppy Muscles | 5.22e-04 | 6 | 176 | 2 | C0427201 | |
| Disease | Unilateral Hypotonia | 5.22e-04 | 6 | 176 | 2 | C0751330 | |
| Disease | mortality | 6.20e-04 | 173 | 176 | 6 | EFO_0004352 | |
| Disease | platelet component distribution width | WEE1 NUP210L WASF3 GATA4 DNM1L ZMIZ1 ZZEF1 HDAC7 NYNRIN LPP DOCK7 NUMB ADAM33 | 6.35e-04 | 755 | 176 | 13 | EFO_0007984 |
| Disease | Stage IV Skin Melanoma | 7.28e-04 | 7 | 176 | 2 | C1321872 | |
| Disease | skin pigmentation | 7.82e-04 | 69 | 176 | 4 | EFO_0003784 | |
| Disease | Hereditary Motor and Sensory Neuropathy Type I | 9.67e-04 | 8 | 176 | 2 | C0751036 | |
| Disease | Roussy-Levy Syndrome (disorder) | 9.67e-04 | 8 | 176 | 2 | C0205713 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.67e-04 | 8 | 176 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth Disease, Type Ib | 9.67e-04 | 8 | 176 | 2 | C0270912 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 9.67e-04 | 8 | 176 | 2 | C0270911 | |
| Disease | cutaneous squamous cell carcinoma | 9.98e-04 | 33 | 176 | 3 | EFO_1001927 | |
| Disease | Colorectal Carcinoma | TET2 TTLL3 GATA4 ADAM29 ZMIZ1 HIVEP3 TGFBR2 NFATC1 CHD5 KDM2A DSEL PDZRN4 | 1.09e-03 | 702 | 176 | 12 | C0009402 |
| Disease | Prostatic Neoplasms | TET2 TBX3 COL15A1 CHST14 WASF3 SULT1E1 TGFBR2 SMARCA1 AHR AKR1C3 MAP3K7 | 1.24e-03 | 616 | 176 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 TBX3 COL15A1 CHST14 WASF3 SULT1E1 TGFBR2 SMARCA1 AHR AKR1C3 MAP3K7 | 1.24e-03 | 616 | 176 | 11 | C0376358 |
| Disease | Acute Confusional Migraine | 1.24e-03 | 9 | 176 | 2 | C0521664 | |
| Disease | Silicosis | 1.24e-03 | 9 | 176 | 2 | C0037116 | |
| Disease | Status Migrainosus | 1.24e-03 | 9 | 176 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 1.24e-03 | 9 | 176 | 2 | C0270858 | |
| Disease | Sick Headaches | 1.24e-03 | 9 | 176 | 2 | C0700438 | |
| Disease | glycogen storage disease (is_implicated_in) | 1.24e-03 | 9 | 176 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | Cervical Migraine Syndrome | 1.24e-03 | 9 | 176 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 1.24e-03 | 9 | 176 | 2 | C0018984 | |
| Disease | Growth Disorders | 1.29e-03 | 36 | 176 | 3 | C0018273 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.40e-03 | 37 | 176 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Optic Atrophy | 1.54e-03 | 10 | 176 | 2 | C0029124 | |
| Disease | Neoplasm Recurrence, Local | 1.63e-03 | 39 | 176 | 3 | C0027643 | |
| Disease | hippocampal CA4 volume | 1.88e-03 | 41 | 176 | 3 | EFO_0009396 | |
| Disease | Eczema, allergic rhinitis | 1.89e-03 | 215 | 176 | 6 | EFO_0005854, HP_0000964 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.93e-03 | 88 | 176 | 4 | EFO_0007006, GO_0036276 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 2.16e-03 | 43 | 176 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | airway wall thickness measurement | 2.24e-03 | 12 | 176 | 2 | EFO_0006898 | |
| Disease | Charcot-Marie-Tooth Disease | 2.24e-03 | 12 | 176 | 2 | C0007959 | |
| Disease | Myopia | 2.27e-03 | 385 | 176 | 8 | HP_0000545 | |
| Disease | Neurodevelopmental Disorders | 2.36e-03 | 93 | 176 | 4 | C1535926 | |
| Disease | C-reactive protein measurement | SOX5 DCHS2 MLEC NUP210L FOSL2 GATA4 SLC6A15 YTHDC2 ZMIZ1 ZZEF1 IL18RAP ACOD1 NYNRIN DOCK7 NUMB MAPK6 | 2.42e-03 | 1206 | 176 | 16 | EFO_0004458 |
| Disease | Liver Cirrhosis, Experimental | ISYNA1 COL12A1 IKBKG NRROS B4GALT5 SULT1E1 TGFBR2 FRY TMEM65 DOCK7 AKR1C3 B9D1 | 2.45e-03 | 774 | 176 | 12 | C0023893 |
| Disease | Abnormality of refraction | DNAJC13 SYN3 ZZEF1 HIVEP3 MAGI2 FRY NFATC1 SUMF1 KCNMA1 AHR CPSF2 | 2.47e-03 | 673 | 176 | 11 | HP_0000539 |
| Disease | colorectal cancer (is_marker_for) | 2.56e-03 | 157 | 176 | 5 | DOID:9256 (is_marker_for) | |
| Disease | folic acid measurement | 2.62e-03 | 46 | 176 | 3 | EFO_0005111 | |
| Disease | Migraine Disorders | 2.64e-03 | 13 | 176 | 2 | C0149931 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.64e-03 | 13 | 176 | 2 | C0270914 | |
| Disease | Neuroblastoma | 2.79e-03 | 47 | 176 | 3 | C0027819 | |
| Disease | chronic kidney disease | 2.95e-03 | 235 | 176 | 6 | EFO_0003884 | |
| Disease | Alzheimer's disease biomarker measurement | 2.96e-03 | 48 | 176 | 3 | EFO_0006514 | |
| Disease | ventricular septal defect (is_implicated_in) | 3.07e-03 | 14 | 176 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | FEV change measurement, response to corticosteroid | 3.07e-03 | 14 | 176 | 2 | EFO_0005921, GO_0031960 | |
| Disease | Pancreatic Neoplasm | 3.07e-03 | 100 | 176 | 4 | C0030297 | |
| Disease | spontaneous preterm birth | 3.19e-03 | 101 | 176 | 4 | EFO_0006917 | |
| Disease | alcohol consumption measurement | MYT1L SOX5 COL12A1 SYN3 WASF3 LGALS12 BRMS1L B4GALT5 ACOD1 MAGI2 KANSL1 IGSF9B MAPK6 MAP3K7 DNAH5 STK24 | 3.23e-03 | 1242 | 176 | 16 | EFO_0007878 |
| Disease | breast carcinoma | TET2 TBX3 TNRC6B SLC6A15 ADAM29 ZMIZ1 KLF4 TASOR2 HIVEP3 TGFBR2 RTKN2 KANSL1 PCSK7 RAB33B | 3.30e-03 | 1019 | 176 | 14 | EFO_0000305 |
| Disease | Malignant neoplasm of pancreas | 3.30e-03 | 102 | 176 | 4 | C0346647 | |
| Disease | mean platelet volume | TET2 NUP210L GATA4 DNM1L FRYL PLXND1 ZMIZ1 HDAC7 FRY NFATC1 DOCK7 HTR3D MAML2 BRD1 | 3.33e-03 | 1020 | 176 | 14 | EFO_0004584 |
| Disease | Situs ambiguus | 3.53e-03 | 15 | 176 | 2 | C0266642 | |
| Disease | caffeine measurement | 3.53e-03 | 15 | 176 | 2 | EFO_0021177 | |
| Disease | B-cell acute lymphoblastic leukemia | 3.53e-03 | 15 | 176 | 2 | EFO_0000094 | |
| Disease | corpus callosum posterior volume measurement | 3.72e-03 | 52 | 176 | 3 | EFO_0010298 | |
| Disease | uric acid measurement | TNIK PRPSAP1 SOX5 TET2 DNAJC13 DCDC1 SYN3 ZMIZ1 NRXN2 NFATC1 | 3.77e-03 | 610 | 176 | 10 | EFO_0004761 |
| Disease | central nervous system disease (implicated_via_orthology) | 4.02e-03 | 16 | 176 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Glycogen storage disease | 4.54e-03 | 17 | 176 | 2 | cv:C0017919 | |
| Disease | Muscle hypotonia | 4.54e-03 | 17 | 176 | 2 | C0026827 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder | 4.54e-03 | 17 | 176 | 2 | EFO_0003761, EFO_0004247, EFO_0005658 | |
| Disease | brain infarction | 5.08e-03 | 18 | 176 | 2 | EFO_0004277 | |
| Disease | caudal middle frontal gyrus volume measurement | 5.08e-03 | 18 | 176 | 2 | EFO_0010290 | |
| Disease | congenital heart disease | 5.31e-03 | 59 | 176 | 3 | EFO_0005207 | |
| Disease | cumulative dose response to bevacizumab | 5.66e-03 | 19 | 176 | 2 | EFO_0005944 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 5.66e-03 | 19 | 176 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | insulin sensitivity measurement, body mass index | 5.66e-03 | 19 | 176 | 2 | EFO_0004340, EFO_0004471 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KMSEARPPPLLGQHT | 401 | Q9HAC7 | |
| PAIMDPLPLRTKNGT | 421 | P35869 | |
| QPRCIMHEGNPPITK | 351 | Q9UKF5 | |
| LIIDPKMPRVPGHHN | 946 | O95696 | |
| CKHPEAILTPMPEGL | 401 | O15013 | |
| PQKMQPAPADGHVRL | 896 | Q9BZ76 | |
| AHLLPAPLGLPDKME | 1556 | Q8TDI0 | |
| MKPRQLIIVHGPPEA | 556 | Q9P2I0 | |
| PIMPASPQKGHAVNL | 611 | O00429 | |
| IHSPMSLKPGEELSP | 116 | P42330 | |
| PLKHPESFIRMGIQP | 646 | Q8NB90 | |
| DPKMPREGLLHNGVP | 1096 | Q9ULD4 | |
| GKPSLLAPHMVPVDS | 581 | Q9BZ11 | |
| QEPEMAPLGPKGLIH | 101 | O00213 | |
| SPSGHPIPSEAKMRL | 246 | P17544 | |
| PHILRVGEPKMSGDL | 346 | Q8NEG7 | |
| NHTCPERLPSMKGPI | 111 | O43286 | |
| ADGPHRNVLKIKPPM | 401 | Q8TBG4 | |
| FTDVLLMAKPRPPLH | 251 | Q8N4T4 | |
| SHKPLMLSQPPDNGI | 201 | Q9H082 | |
| MKDHRPALLPTQPPV | 301 | Q96EV2 | |
| EHIMALAKLRPPTPP | 341 | Q6ZMN7 | |
| KDNDFLLHGHRPPMP | 116 | Q86V24 | |
| HKMERPGPSLKRVGP | 506 | Q9NPH2 | |
| GTPHFMAPEVVKREP | 181 | O14936 | |
| GLKQLPEPSDTHLMP | 821 | M0R2J8 | |
| RLSPKQVPEHLPFMG | 61 | O95256 | |
| EELSHMKRLPPVLPG | 46 | O43474 | |
| DFPLHLGKNVVGRMP | 46 | Q14676 | |
| NMPHTELGTKPLQAP | 391 | Q86UL8 | |
| LGPMIPLPVKDQDHT | 496 | Q96JE9 | |
| TSPKLMRHDPLLIPG | 781 | Q12791 | |
| PIPMECLGKHEVSPL | 636 | Q6ZNB6 | |
| GPHQVPLDLVSRMKP | 41 | Q9UHF5 | |
| MAGTVDDVPKLQPHP | 211 | Q14165 | |
| NPHTVDRVPMGKLPH | 386 | P46020 | |
| SLHRPAQPLKPQIAM | 2161 | Q2LD37 | |
| PKGITIPQREKPGHM | 16 | Q9GZW8 | |
| MPKGRQKVPHLDAPL | 1 | Q16549 | |
| PLVHSLEPTMGPKAG | 981 | Q9Y4D7 | |
| PAGHPFLLMSPRLEV | 196 | Q96DT0 | |
| MTEPHKPLTQLLPGI | 271 | Q16659 | |
| KEETCLDPQHPVMPR | 161 | Q96LB9 | |
| LKVMEHNQGEPLPFP | 1556 | O94915 | |
| SMQPKALIHRDLKPP | 146 | O43318 | |
| TLMPAAPGVSPKLHD | 756 | O95644 | |
| PAGKMNHRDPLQPLL | 1561 | Q9P2S2 | |
| KHRAPMPGSLPDSAR | 706 | Q7Z3B3 | |
| ALMDKPVPLSPGLQH | 496 | Q6B0I6 | |
| TPVTGHKRMVIPNQP | 156 | Q93052 | |
| HKRMVIPNQPPLTAT | 161 | Q93052 | |
| SPLGKPAMLHLPSEQ | 31 | Q9Y6K9 | |
| MRKRHVEVSQAPLPP | 356 | Q9Y6K9 | |
| RLPPHPAMSEKTQQG | 6 | A6NEY3 | |
| RLPPHPAMSEKTQQG | 6 | A6NEM1 | |
| RLPPHPAMSEKTQQG | 6 | A6NI86 | |
| RLPPHPAMSEKTQQG | 6 | H0YKK7 | |
| PKPALIGHRGAPMLA | 226 | Q8WTR4 | |
| VNKGHEMSPQAPRRP | 401 | Q13421 | |
| MRNHKIAPGLPPQNF | 126 | Q02078 | |
| LTPALMPKHPNSLSG | 411 | Q8IVE3 | |
| EPAMKRPRTAGPAVH | 416 | Q9Y2X0 | |
| SEDVRLMKPPSPEHQ | 846 | Q9Y6X9 | |
| MPAVNLGQVPPKHPR | 3296 | Q6V1P9 | |
| HPQPLGLPMASVICL | 281 | O76062 | |
| HPAMEPRQGNTKPLF | 546 | Q8IZL2 | |
| KRHPVRPIIHPNAME | 516 | O43283 | |
| APNLPAGKMNHRDPL | 511 | P58401 | |
| VLPQNIHPMRKACPS | 496 | Q96M91 | |
| LHGVPRPLAMRKEGI | 301 | P43694 | |
| ATLGHLMMPKPPNLI | 2431 | P46100 | |
| CHQKPMPSLPQLEER | 316 | O60308 | |
| PRIPHMKDPIGDSFQ | 336 | P26951 | |
| HTMKPAPRLTPVRPA | 541 | Q9Y2K7 | |
| SEQMKGLLRPHVPPA | 306 | Q96N67 | |
| RPHGRGKQMVAKVPP | 1031 | Q99715 | |
| IPEHKPFQGMDPIRV | 206 | Q06889 | |
| TLPGMARPIQVKPAD | 111 | Q8N6W0 | |
| ELPAHRAEMEILPKP | 241 | Q8WXX0 | |
| APVPGKTLHLPIMGV | 216 | Q8IWF6 | |
| VPGHMALPRPGVIKT | 91 | P15408 | |
| RPHLPLLMGGQAALK | 311 | Q8TBE0 | |
| PPLGHLPKVIQAMNH | 2046 | O75165 | |
| NGHMPVPIPSLDRAA | 381 | P41970 | |
| PAVPLKTDHPVMGIQ | 86 | Q8TC29 | |
| LHKQLPPPQVGMDRI | 191 | O94769 | |
| PRVPAPKTRNNMPHL | 826 | Q6UXX5 | |
| PKTRNNMPHLGPGIL | 831 | Q6UXX5 | |
| NMPHLGPGILLSKTP | 836 | Q6UXX5 | |
| PGEEMPHLARPIKVE | 466 | Q08050 | |
| ANDMPKRFHPPSVVG | 151 | A6NK06 | |
| ILPHIPLKSFPGMER | 151 | Q99518 | |
| PKAMPVEVLGHLPKR | 16 | Q587J8 | |
| LPMKHPLQSLGRPED | 1256 | Q9ULL0 | |
| QPGHSKTQRPEEMPI | 301 | Q9BXC0 | |
| PPMVKNATVHPGLEL | 216 | Q14558 | |
| MATLGPHRVKTEPPV | 231 | Q5PSV4 | |
| IHMVNNFRPPQPLKG | 241 | P43166 | |
| RPMLGIKPHLQQKEP | 1316 | Q05BV3 | |
| GTHREKGPPTMLPIN | 41 | Q5TBA9 | |
| IPLTPQHAQALGMPL | 1361 | A6NE01 | |
| PGPMQPRLEQLKTHV | 371 | Q8WUI4 | |
| SPGRHKRTIPMFVPE | 111 | Q9UPM9 | |
| LRKCPKEMGPHVPNV | 286 | O75155 | |
| KMPVDTAHPGSPELI | 966 | P39059 | |
| KHRPKDGPMVPSTAQ | 366 | Q8IZU8 | |
| PQKMQPAPADGHVRL | 896 | Q96NU0 | |
| RIPMAPNCKIIFEPH | 2366 | Q8TE73 | |
| HISNQKMPTGPPEDR | 61 | Q6PGQ1 | |
| PISHLPGSLMEPVEK | 46 | Q969Z0 | |
| NPHTVDRVPMGKVPH | 386 | P46019 | |
| PPHARMLTLDANPLK | 56 | Q86YC3 | |
| FTLLKEGIQRPGPMH | 601 | Q5VU65 | |
| DVPAPTVSPHAMGKR | 1461 | Q9P2P1 | |
| FHGIRPPQLEQPEKM | 216 | O94955 | |
| HPEAAQPGQVPMRKR | 181 | Q8N9Y4 | |
| NHKEPPRLPLKMEGT | 841 | A8MW92 | |
| LAKPAHTALAPVAMP | 376 | P49757 | |
| KCLFGLHARMPPPVE | 326 | O43189 | |
| RHPDLPFPEITKMLG | 91 | Q9P0W2 | |
| HLQKPMAAPRKLLPA | 551 | Q8IZC4 | |
| PMVTAPHFPVVVKLG | 236 | O14994 | |
| APHPLPSADMIPKRL | 1696 | Q5TCS8 | |
| LIHGKIPSEMPSPNF | 676 | Q9H2J7 | |
| LGPQAHLRPLKTMEP | 81 | O15119 | |
| IPGPHMVLVPKSTLH | 231 | P28370 | |
| PLTEVSLPMAKQPGR | 96 | Q6ZMQ8 | |
| VMLGQRPKNPIHNIP | 316 | Q6T4R5 | |
| VAHSPLAAQLKPMTP | 241 | Q9HCE1 | |
| RGEPPHSELHPMKVL | 226 | Q9Y6E0 | |
| DPPDQKNRLMPLSHL | 51 | Q8NBL3 | |
| HMGPIKLRQFHRPPL | 606 | P21675 | |
| RLDGNEIKPPIPMAL | 326 | O60938 | |
| PSPQHPQKMDGELGR | 311 | Q9H0F6 | |
| TPCGRPKMPIVHRDL | 366 | P37173 | |
| PPTVMPGGDLAKVHR | 366 | A6NHL2 | |
| PAGPLRDKVHPMILA | 136 | Q9BUU2 | |
| PGERQLAHSKMVPIP | 81 | Q8NBK3 | |
| ATLNQMHRLGPPKRP | 31 | O15235 | |
| GAEMAPIRIFHKEPP | 146 | Q96GD3 | |
| MPLHQLGDKPLTFPS | 1 | Q96BD0 | |
| MQKHSPGPPALALLS | 1 | Q70Z44 | |
| AAREILLMPTPGKHG | 371 | Q9UM73 | |
| EVRIHPSKGPLPFQM | 5296 | Q8IVF2 | |
| PKRTVSAPRMLGHQP | 401 | Q9BWW9 | |
| APFKPSEPGANMRHI | 931 | Q8IYE0 | |
| TPPRQHLPAHEKMVQ | 461 | O15516 | |
| ERGILAEMKPLPLHP | 61 | Q8NCH0 | |
| EPPQIASPKMHRSVL | 276 | Q96M02 | |
| GPLKPLMEATLPGHR | 71 | Q9UQ49 | |
| RAHPVMLKQTPVLPP | 371 | Q92759 | |
| MPHKVANRISDPNLP | 551 | Q9UKE5 | |
| MPSVEHEKPARPEGQ | 936 | Q70EL4 | |
| HPDPERRPSAMALVK | 551 | P30291 | |
| TVMAPNLFLHQGRPP | 426 | Q5TG30 | |
| DEMNSPRIVKTHLPP | 96 | P49888 | |
| PKALPSTGPHSLRDM | 6 | Q5VWJ9 | |
| RVIGMGVPHSKRLLP | 246 | Q96AG3 | |
| MGQSAPARLVLKDPP | 406 | Q9UPX0 | |
| MNQLSSGIPVPKPRH | 681 | Q9P246 | |
| DPKPEAILTPLMHNG | 716 | Q9H2E6 | |
| SSPMHGPPVAEAKRQ | 416 | Q9UPY6 | |
| QMVQARPGAHPTLLP | 2201 | Q5T1R4 | |
| PSAILQPRQHPSKML | 271 | Q96DN2 | |
| QAPKEPALHPMGLSL | 31 | Q9H1D0 | |
| RLPDKPLCQHMPRLH | 236 | Q9HBX9 | |
| EKKMVHRSGPTLLPP | 41 | Q9Y4R7 | |
| PMPPAQDHKRLLEGD | 211 | P22102 | |
| PRRLGTHPKKEPMEA | 51 | Q6PI78 | |
| RVLMKSPSPALHPPQ | 1216 | Q9H6S0 | |
| VHGDIFRPPRKGMLL | 351 | Q99805 | |
| PDRGHPHQEMPSKLG | 21 | O95201 | |
| PHQEMPSKLGEAVPS | 26 | O95201 | |
| QKALRHMPPLSLSPG | 426 | O43149 | |
| HMPALRINSGAGPLK | 416 | P35711 | |
| EQEMLHKHSPPRGRP | 161 | Q9Y2Y4 | |
| PEAATPVGKVMPFRH | 686 | Q5VWN6 | |
| PVGKVMPFRHQPGLL | 691 | Q5VWN6 | |
| MPFRHQPGLLLQQKP | 696 | Q5VWN6 | |
| KTCHGPPLIRTMPRS | 806 | Q9UL62 | |
| SEHKGLPMPRLQALP | 1216 | P48553 | |
| RNIPGPHMVLVPKST | 226 | O60264 | |
| RPMSEHLKHNPPIFG | 506 | Q6N021 | |
| TAMHPSLPRNIAPKP | 386 | O94900 | |
| LRNPPKLVTPHDRMA | 316 | P29353 | |
| HQKSRQSDPPGKLPM | 111 | Q9ULJ6 | |
| VGPKPHLDNMVPNAL | 1341 | Q9UPQ9 | |
| AQKLGEPPVLPVSRM | 456 | Q5R3F8 | |
| GRIDPRVNPLKMSPH | 936 | P23378 | |
| NLCRHKDPPPPMETI | 226 | O00629 | |
| TRVKHEAMELPPAGP | 171 | Q96BF6 | |
| PHKDRVPPEILAMHE | 531 | Q9UL68 | |
| HSKLLRSPPQMEGPD | 101 | Q96T66 | |
| RSPPQMEGPDHGKAL | 106 | Q96T66 |